Cargando...
Epigenetics in osteoarthritis: Potential of HDAC inhibitors as therapeutics
Osteoarthritis (OA) is the most common joint disease and the leading cause of chronic disability in middle-aged and older populations worldwide. The development of disease modifying therapy for OA is in its infancy largely because the regulatory mechanisms for the molecular effectors of OA pathogene...
Gardado en:
| Publicado en: | Pharmacol Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803377/ https://ncbi.nlm.nih.gov/pubmed/28827187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2017.08.007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|